200347-61-1

Basic information

• Product Name: N-benzyl-1-(6'-bromo-3'-indolyl)-2-tert-butoxycarbonylamino-N-hydroxyethylamine
• Synonyms: N-benzyl-1-(6'-bromo-3'-indolyl)-2-tert-butoxycarbonylamino-N-hydroxyethylamine
• CAS NO: 200347-61-1
• Molecular Weight: 460.371
• Mol File: 200347-61-1.mol
• Article Data: 7

Chemical Properties

• CAS DataBase Reference: N-benzyl-1-(6'-bromo-3'-indolyl)-2-tert-butoxycarbonylamino-N-hydroxyethylamine(CAS DataBase Reference)
• NIST Chemistry Reference: N-benzyl-1-(6'-bromo-3'-indolyl)-2-tert-butoxycarbonylamino-N-hydroxyethylamine(200347-61-1)
• EPA Substance Registry System: N-benzyl-1-(6'-bromo-3'-indolyl)-2-tert-butoxycarbonylamino-N-hydroxyethylamine(200347-61-1)

Safety Data

• Hazardous Substances Data: 200347-61-1(Hazardous Substances Data)

Upstream product

• 52415-29-9 6-bromo-1H-indole 

Downstream Products

• 952235-32-4 N-(benzylidene)-2-[N'-(tert-butoxycarbonyl)amino]-1-(6'-bromoindol-3'-yl)ethanamine N-oxide 

Relevant articles and documents

NOVEL BIS-INDOLIC DERIVATIVES, A PROCESS FOR PREPARING THE SAME AND THEIR USES AS A DRUG

The present invention relates to novel bis-indolic derivatives, processes for their preparation, and their potential use as new antibacterial drugs.

BIS-INDOLIC DERIVATIVES, THEIR USES IN PARTICULAR AS ANTIBACTERIALS

The present invention relates to novel bis-indolic derivatives, processes for their preparation, and their potential use as new antibacterial drugs.

NOVEL INDOLIC DERIVATIVES, THEIR PREPARATION PROCESSES AND THEIR USES IN PARTICULAR AS ANTIBACTERIALS

The invention relates to the use of at least one compound of the formula (I), in which R and R3 are particularly a hydrogen atom, R1 is particularly a hydrogen atom or a methyl, ethyl or isobutyl mi group, R4, R5, R6 and R7 are independently a hydrogen atony, an alkoxyl group with 1 to 7 carbon atoms or a halogen atom, R2 is a hydrogen atom, an O? group or an OH group, B is an N-GP1 or NRc, group, GP1 being a Boc or Cbz group, and Rc is a hydrogen atom or a methyl or t-butyl group, for preparing a drug for treating conditions associated with bacterial infections, in particular for treating bacterial diseases.